PLUR Stock Summary and Trading Ideas (Pluri | NASDAQ:PLUR)

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Pluri trades on the NASDAQ stock market under the symbol PLUR.

As of June 12, 2026, PLUR stock price climbed to $2.27 with 8,584 million shares trading.

PLUR has a market cap of $24.49 million. This is considered a Sub-Micro Cap stock.

Last quarter Pluri reported $167,000 in Revenue and -$.55 earnings per share. This fell short of revenue expectation by $-488,000 and exceeded earnings estimates by $.11.

In the last 3 years, PLUR traded as high as $8.56 and as low as $2.22.

PLUR has underperformed the market in the last year with a price return of -47.2% while the SPY ETF gained +24.1%. PLUR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -29.7% and -2.2%, respectively, while the SPY returned +11.6% and -1.9%, respectively.

PLUR support price is $2.07 and resistance is $2.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLUR shares will trade within this expected range on the day.